SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
14-Feb-24 8:23 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-24 | Grant | 3,320 | -- | -- | 9% 36.74K to 40.06K | |
14-Feb-24 8:23 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-24 | Payment of Exercise | 973 | $12.41 | $12,074.90 | (2%) 40.06K to 39.08K | |
06-Dec-23 8:31 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 05-Dec-23 | Sale | 2,125 | $9.63 | $20,463.80 | (5%) 38.86K to 36.74K | |
05-Dec-23 9:24 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 01-Dec-23 | Payment of Exercise | 753 | $9.49 | $7,145.97 | (2%) 39.61K to 38.86K | |
15-Feb-23 9:54 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 13-Feb-23 | Grant | 20,305 | -- | -- | 79% 25.73K to 46.03K | |
15-Feb-23 9:54 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 13-Feb-23 | Payment of Exercise | 6,416 | $52.77 | $338,572.00 | (14%) 46.03K to 39.61K | |
05-Dec-22 7:30 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 01-Dec-22 | Payment of Exercise | 498 | $44.33 | $22,076.30 | (2%) 26.22K to 25.73K | |
28-Nov-22 6:41 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 23-Nov-22 | Grant | 18,500 | -- | -- | 240% 7.72K to 26.22K | |
15-Feb-22 9:54 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 14-Feb-22 | Grant | 1,412 | -- | -- | 21% 6.8K to 8.21K | |
15-Feb-22 9:54 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 14-Feb-22 | Payment of Exercise | 489 | $62.49 | $30,557.60 | (6%) 8.21K to 7.72K | |
23-Nov-21 8:04 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 19-Nov-21 | Grant | 6,800 | -- | -- | 100% 0 to 6.8K |